ExactAntigen

AFP Antibody Review
back to AFP antibodies
This is a review about AFP antibodies, based on 3 published articles using AFP antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited AFP antibody. Information in this review (with links to publications) can be searched freely.
list by method: blocking or activating experiments (block), immunocytochemistry (ic), immunoprecipitation (ip)
SANTA CRUZ BIOTECHNOLOGY    search SANTA CRUZ BIOTECHNOLOGY AFP products
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES
block    Santa Cruz Biotechnology antibody against AFP was used in blocking experiment to study the proangiogenic activity of AFP in the fetomaternal unit and its possible role during pregnancy in the present study
SIGMA    search SIGMA AFP products
Other Brands or Spellings: SIGMA-ALDRICH, SIGMA CHEMICAL, SIGMA CHEMICAL COMPANY, SIGMA-ALDRICH FINE CHEMICALS
ic    Sigma alpha-fetoprotein monoclonal antibody was used in immunocytochemistry to study OCT4 express in human embryonic stem cell clones
CALBIOCHEM
Other Brands or Spellings: ONCOGENE, ONCOGENE RESEARCH, ONCOGENE RESEARCH PRODUCTS, MERCK BIOSCIENCES, ONCOGENE SCIENCES, ONCOGENE SCIENCE
ip    Calbiochem monoclonal anti-AFP antibody was used in immunoprecipitation to study the function of Eukaryotic Translation Initiation Factor 4GI (eIF4GI) and the expression of its from several distinct mRNAs


Articles Reviewed
1. Olin D Liang et al. Oncodevelopmental alpha-fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit. 2004
2. Lesley Gerrard et al. Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. 2005
3. Marshall P Byrd et al. Translation of eukaryotic translation initiation factor 4GI (eIF4GI) proceeds from multiple mRNAs containing a novel cap-dependent internal ribosome entry site (IRES) that is active during poliovirus infection. 2005


2007 ©ExactAntigen Home | Browse | About us